Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors
Zarnack, S.; Bekemeier, H.; Giessler, A.J.
Die Pharmazie 43(5): 337-338
1988
ISSN/ISBN: 0031-7144 PMID: 3140256 Document Number: 319227
The ear edema of the mouse induced by local application of arachidonic acid is suitable for in vivo differentiation of lipoxygenase (LOX) and cyclooxygenase (COX) inhibitors. LOX blockers inhibit initially and plateau-like during the first hour of the course of the edema, while COX-blockers do so mostly only initially. For practice we recommend the measurement about 60 min following edema provocation. The dual blocker of LOX and COX, BW 755 c, acts like a LOX inhibitor.
Document emailed within 1 workday
Related Documents
Bekemeier, H.; Hirschelmann, R.; Ramanampison, M.L.; Pantović, D. 1986: Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat Die Pharmazie 41(6): 406-408Panossian, A.G. 1984: Inhibition of arachidonic acid 5-lipoxygenase of human polymorphonuclear leukocytes by esculetin Biomedica Biochimica Acta 43(12): 1351-1355
Bourgain, R.H.; Andries, R.; Finne, E.; Vanden Driessche, R.J.; Bernard, P.J. 1982: The effect of the inhibition of PGI2-synthetase and lipoxygenase and of arachidonic acid on platelet-vessel wall interaction Archives Internationales de Pharmacodynamie et de Therapie 259(2): 305-307
Kelly, J.P.; Johnson, M.C.; Parker, C.W. 1979: Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway Journal of Immunology 122(4): 1563-1571
Madan, Z.M.; Sainani, G.S. 2000: Effects of cyclo-oxygenase and thromboxane synthetase inhibitors on right atrial prostaglandins Journal of the Association of Physicians of India 48(6): 581-583
Turner, C.R.; Quinlan, M.F.; Schwartz, L.W.; Wheeldon, E.B. 1990: Therapeutic intervention in a rat model of ARDS: I. Dual inhibition of arachidonic acid metabolism Circulatory Shock 32(3): 231-242
Meek, A.C.; McCollum, C.N.; Greenhalgh, R.M. 1987: The effect of cyclo-oxygenase inhibition on thrombogenicity following carotid endarterectomy Progress in Clinical and Biological Research 242: 399-402
Senna, G.; Bilò, M.B.; Antonicelli, L.; Schiappoli, M.; Crivellaro, M.A.; Bonadonna, P.; Dama, A.R. 2004: Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients European Annals of Allergy and Clinical Immunology 36(6): 215-218
Suffys, P.; Beyaert, R.; Van Roy, F.; Fiers, W. 1987: Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism Biochemical and Biophysical Research Communications 149(2): 735-743
Uotila, P.; Vargas, R.; Wroblewska, B.; d'Alarcao, M.; Matsuda, S.P.; Corey, E.J.; Cunard, C.M.; Ramwell, P.W. 1987: Relaxing effects of 15-lipoxygenase products of arachidonic acid on rat aorta Journal of Pharmacology and Experimental Therapeutics 242(3): 945-949
Ford-Hutchinson, A.W.; Bray, M.A.; Smith, M.J. 1979: The aggregation of rat neutrophils by arachidonic acid: a possible bioassay for lipoxygenase activity Journal of Pharmacy and Pharmacology 31(12): 868-869
Vacher, P.; McKenzie, J.; Dufy, B. 1992: Complex effects of arachidonic acid and its lipoxygenase products on cytosolic calcium in GH3 cells American Journal of Physiology 263(5 Pt 1): E903-E912
Gay, R.E.; Neidhart, M.; Pataky, F.; Tries, S.; Laufer, S.; Gay, S. 2001: Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis Journal of Rheumatology 28(9): 2060-2065
Gualde, N.; Atluru, D.; Goodwin, J.S. 1985: Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets Journal of Immunology 134(2): 1125-1129
Grossi, I.M.; Fitzgerald, L.A.; Umbarger, L.A.; Nelson, K.K.; Diglio, C.A.; Taylor, J.D.; Honn, K.V. 1989: Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid Cancer Research 49(4): 1029-1037
Hanna, N.; Marshall, P.J.; Newton, J.; Schwartz, L.; Kirsh, R.; Dimartino, M.J.; Adams, J.; Bender, P.; Griswold, D.E. 1990: Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism Drugs under Experimental and Clinical Research 16(4): 137-147
Boda, Z.; Tamás, E.; Neuwirth, G.; Altorjay, I.; Rák, K. 1981: Thrombocytopathy caused by congenital cyclo-oxygenase deficiency Orvosi Hetilap 122(19): 1121-1124
Rand, T.H.; Turk, J.; Maas, R.L.; Colley, D.G. 1982: Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter Journal of Immunology 129(3): 1239-1244
Pagella, P.G.; Agozzino, S.; Bellavite, O.; Donà, G.C. 1984: Reversible inhibition of thromboxane A2 production by imidazole 2-hydroxybenzoate (ITF 182) in the arachidonic acid injected rat. a comparison with acetylsalicylic acid and indometacin Arzneimittel-Forschung 34(5): 597-598
Falkenhein, S.F.; Macdonald, H.; Huber, M.M.; Koch, D.; Parker, C.W. 1980: Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway Journal of Immunology 125(1): 163-168